BUONAMICO, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 296
EU - Europa 137
AS - Asia 46
OC - Oceania 1
Totale 480
Nazione #
US - Stati Uniti d'America 296
IT - Italia 49
SE - Svezia 43
SG - Singapore 26
DE - Germania 14
CZ - Repubblica Ceca 12
CN - Cina 10
IN - India 5
FI - Finlandia 4
IE - Irlanda 4
FR - Francia 3
GB - Regno Unito 3
ES - Italia 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
IR - Iran 1
KG - Kirghizistan 1
LT - Lituania 1
NL - Olanda 1
Totale 480
Città #
Chandler 56
Nyköping 41
New York 38
Ashburn 27
Fairfield 20
Singapore 16
Munich 12
Olomouc 12
Woodbridge 11
Cambridge 9
Rome 9
Lawrence 8
Wilmington 8
Bari 6
San Diego 6
Inglewood 5
Pune 5
Seattle 5
Turi 5
Des Moines 4
Dublin 4
Helsinki 4
Houston 4
Milan 4
Princeton 4
Roxbury 4
Santa Clara 4
Los Angeles 3
Aprilia 2
Beijing 2
Ciudad Real 2
Dong Ket 2
Palermo 2
Ann Arbor 1
Baku 1
Bishkek 1
Bitritto 1
Boardman 1
Brisbane 1
Chiswick 1
Cisternino 1
Copertino 1
Guangzhou 1
London 1
Marseille 1
Monza 1
Paris 1
San Severo 1
Shanghai 1
Stockholm 1
Strasbourg 1
Usingen 1
Zibo 1
Totale 364
Nome #
The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase 53
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 50
Omalizumab as add-on therapy in a patient with severe asthma and OSA 47
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 46
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 42
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 36
Breathing rhythm variations during wash-in do not influence exhaled volatile organic compound profile analyzed by an electronic nose 32
Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19 30
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 26
Correlation between nasal inflammation assessed by nasal cytology and blood neutrophil-to-lymphocyte ratio in patients with copd 24
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 23
Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 20
The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit 17
Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study 15
Predictive machine learning models and survival analysis for covid-19 prognosis based on hematochemical parameters 14
Asthma and Fixed Airways Obstruction: Real Life Aspects 10
The Predictors of Long COVID in Southeastern Italy 7
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 5
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience 4
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development? 3
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 2
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 2
Totale 508
Categoria #
all - tutte 4.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 3 8 0
2020/202155 5 2 4 5 4 0 12 5 4 4 3 7
2021/202254 2 0 0 4 0 7 1 6 3 5 9 17
2022/2023149 10 21 13 11 14 18 3 24 23 3 7 2
2023/2024153 10 18 5 8 11 60 4 4 6 1 6 20
2024/202586 23 9 16 23 15 0 0 0 0 0 0 0
Totale 508